Cholesterol succinyl chitosan anchored liposomes: preparation, characterization, physical stability, and drug release behavior

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 6, Issue 3, 2010, Pages 471-477

  Wang, Yinsong ^a   Tu, Shaoli ^b   Li, Rongshan ^a   Yang, XiaoYing ^a   Liu, Lingrong ^b   Zhang, Qiqing ^b,c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

^c XIAMEN UNIVERSITY   (China)

Author keywords

Cholesterol succinyl chitosan; Drug carrier; Epirubicin; Polysaccharide anchored liposome

Indexed keywords

BODY FLUIDS; BUFFER STORAGE; CHITIN; CHOLESTEROL; LIPOSOMES; PHOSPHOLIPIDS; STABILITY; SYNTHESIS (CHEMICAL); ZETA POTENTIAL;

CORE STRUCTURE; DELIVERY VEHICLE; DRUG CARRIER; DRUG RELEASE; EPIRUBICIN; FETAL BOVINE SERUM; IN-VITRO; MODEL DRUGS; PHOSPHATE BUFFER SOLUTIONS; PHYSICAL STABILITY; SUBSTITUTION DEGREE; SUSTAINED RELEASE;

CHITOSAN;

BUFFER; CHOLESTEROL SUCCINYL CHITOSAN ANCHORED LIPOSOME; DRUG CARRIER; EPIRUBICIN; LIPOSOME; UNCLASSIFIED DRUG; CHITOSAN; CHOLESTEROL;

ARTICLE; CONTROLLED STUDY; ENCAPSULATION; LIPOSOMAL DELIVERY; MOLECULAR STABILITY; PARTICLE SIZE; STORAGE TEMPERATURE; SUSTAINED DRUG RELEASE; SYNTHESIS; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; ANIMAL; BOVINAE; CHEMISTRY; DRUG DELIVERY SYSTEM; TRANSMISSION ELECTRON MICROSCOPY;

BOVINAE;

ANIMALS; CATTLE; CHITOSAN; CHOLESTEROL; DRUG DELIVERY SYSTEMS; EPIRUBICIN; LIPOSOMES; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE;

EID: 77952692576     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2009.09.005     Document Type: Article

References (27)

1. Gregoriadis G. Antimicrob J. Overview of liposomes. J Antimicrob Chemoth 28 (1991) 39-48
2. Park Y.S., Maruyama K., and Huang L. Some negatively charged phospholipids derivatives prolong the liposome circulation in vivo. Biochim Biophys Acta 1108 (1992) 257-260
3. Lukyanov A.N., Elbayoumi T.A., Chakilam A.R., and Torchilin V.P. Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. J Controlled Release 100 (2004) 135-144
4. Sharma A., and Sharma U.S. Liposomes in drug delivery: progress and limitations. Int J Pharm 154 (1997) 123-140
5. Garg M., Dutta T., and Jain N.K. Stavudine-loaded O-palmitoyl-anchored carbohydrate-coated liposomes. AAPS PharmSciTech 8 (2007) E86-E93
6. Matsukawa S., Yamamoto M., Ichinose K., Akiyoshi K., and Sunamoto J. Selective uptake by cancer cells of liposomes coated with polysaccharides bearing 1-aminolactose. Anticancer Res 20 (2000) 2339-2344
7. Cheng J., Zhu J.B., Yang S.X., and Wang C.B. Preparation of amylopectin modified dipyridamole liposome and its tissue distribution in mice. Acta Pharm Sinica 41 (2006) 277-281
8. Cheng J., Zhu J.B., Wen N., and Xiong F. Stability and pharmacokinetic studies of O-palmitoyl amylopectin anchored dipyridamole liposomes. Int J Pharm 313 (2006) 136-143
9. Sihorkar V., and Vyas S.P. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. J Pharm Pharm Sci 4 (2001) 138-158
10. Kang E.C., Aklyoshi K., and Sunamoto J. Surface coating of liposomes with hydrophobized polysaccharides. J Bioact Compat Polym 12 (1997) 14-26
11. Fini A., and Orienti I. The role of chitosan in drug delivery: current and potential applications. Am J Drug Deliv 1 (2003) 43-59
12. Ravi K.M.N.V., Muzzarelli R.A.A., Muzzarelli C., Sashiwa H., and Domb A.J. Chitosan chemistry and pharmaceutical perspectives. Chem Rev 104 (2004) 6017-6084
13. Mourya V.K., and Inamdar N.N. Chitosan-modifications and applications: opportunities galore. React Funct Polym 68 (2008) 1013-1051
14. Wang Y.S., Liu L.R., Weng J., and Zhang Q.Q. Preparation and characterization of self-aggregated nanoparticles of cholesterol-modified O-carboxymethyl chitosan conjugates. Carbohydr Polym 69 (2007) 597-606
15. Chen H.F., Fan S.R., and Hu Y. The determination of substitution degree of carboxymethyl chitosan by colloid titration. J Instr Anal 22 (2003) 70-73
16. Torchilin V.P., and Weissig V. Liposomes (2003), Oxford University Press, New York
17. Hwang S.H., Maitani Y., Qi X.R., Takayama K., and Nagai T. Remote loading of diclofenac, insulin and FITC-insulin into liposomes by pH and acetate gradient methods. Int J Pharm 179 (1999) 85-95
18. Jain S.K., Chourasia M.K., Jain A.K., Chalasani K.B., Soni V., and Jain A. Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium. AAPS PharmSciTech 6 (2005) E35-E41
19. Harrigan P.R., Wong K.F., Redelmeier T.E., Wheeler J.J., and Cullis P.R. Accumulation of doxorubicin and other lipophilic amines into large unilamellar vesicles in response to transmembrane pH gradients. Biochim Biophys Acta 1149 (1993) 329-338
20. Gilad H., Rivka C., Liliana K., and Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of. amphipathic weak bases. Biochim Biophys Acta 1151 (1993) 201-215
21. Zhao Y., Deng Y.H., Xiao L.Y., Lei J.J., and Wang S.N. Study on influencing factors in preparation of vincristine sulfate liposomes by active loading method. Chin Pharm J 40 (2005) 1717-1720
22. Guo J., Ping Q., Jiang G., Huang L., and Tong Y. Chitosan-coated liposomes: characterization and interaction with leuprolide. Int J Pharm 260 (2003) 167-173
23. Takeuchi H., Matsui Y., Sugihara H., Yamamoto H., and Kawashima Y. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm 303 (2005) 160-170
24. Wu Z.H., Ping Q.N., Lei X.M., Li J.Y., and Cai P. Effects of the liposomes coated by chitosan and its derivatives on the gastrointestinal transit of insulin. Acta Pharm Sinica 40 (2005) 618-622
25. Zheng A.P., Wang J.C., Lu W.L., Zhang X., Zhang H., Wang X.Q., et al. Thymopentin-loaded pH-sensitive chitosan nanoparticles for oral administration: preparation, characterization, and pharmacodynamics. J Nanosci Nanotechnol 6 (2006) 2936-2944
26. Cersosimo R.J., and Hong W.K. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. J Clin Oncol 14 (1986) 425-439
27. Bonadonna G., Gianni L., Santoro A., Bonfante V., Bidoli P., Casali P., et al. Drugs ten years later: epirubicin. Ann Oncol 4 (1993) 359-369